DPK-DTMT-01

Modeling prometastatic and proangiogenic upregulation of host and cancer cells by specific inducing factors in association with inhibitors for which molecular target identification has been proposed.

DPK-DTMT-02

In vitro cross-linking reaction for those natural or synthetic peptide inhibitors bound to intra/ extracellular endogenous molecules.

DPK-DTMT-03

2D-PAGE for the separation of inhibitor-endogenous molecular target complexes.

DPK-DTMT-04

MALDI-TOF mass spectrometric identification of endogenous molecular targets.

DPK-DTMT-05

Alternative procedures can also be used for the separation of inhibitor-endogenous molecular target complexes, such as affinity chromatography and immune-precipitation.